Sandoz shares leap nearly 6% after Jefferies ups to 'buy'

Sandoz AG

12/02/2026 09:30

** Sandoz shares rise 5.6%, on track for the best day since August 2025, after Jefferies upgraded the Swiss generic drugmaker to "buy" from "hold"

** Jefferies says it previously underestimated the company's terminal value and profitable growth delivery, pointing to long-term innovation, industry positioning and recent disclosure of its pipeline

** The broker adds that potential regulatory changes to relax clinical trial requirements may accelerate pipeline development through cost cuts and market research expansion

** It notes regulatory initiatives also have a potential to increase competition and pricing pressure

** It raises the company's target price by 20% to 75 Swiss francs ($97)

($1 = 0.7694 Swiss francs)

 (Reporting by Danny Callaghan)

 ((danny.callaghan@thomsonreuters.com))